The 15th International Congress of Toxicology (ICTXV 2019) will take place in Hawaii, HI from July 15-18. The ICTXV is a forum for scientists in academia, government, and industry from around the world to learn about the latest developments in toxicological science and regulation. Our VP of DMPK, Dr. Baomin Xin, will attend the conferenceRead more
Press Events
By medicilon | Press Events | 7 June, 2019 |
Recently, ImmuneOnco Biopharma, a partner of Shanghai Medicilon Inc., announced that its newly developed immune checkpoint inhibitor has been approved by the National Medical Products Administration (NMPA), which marks the beginning of a new phase of research on the first CD47 fusion protein drug in China. It is reported that ImmuneOnco Biopharma submitted the INDRead more
By medicilon | Uncategorized | 4 June, 2019 |
The 2019 BIO International Conference (BIO) will take place in Philadelphia, PA from June 3-6. The BIO attracts 16,000 biotechnology and pharma leaders who come together for one week of intensive networking to discover new opportunities and promising partnerships. Our Directors of BD, Dr. Walter Xie, Dr. Mingzhu Zhang and Sally Tang will attend theRead more
By medicilon | Our Events | 10 January, 2019 |
Medicilon held the Preclincial and IND Declaration Seminar in Chengdu, China. Medicilon CEO Chun-Lin Chen gave a speech during the seminar where he shared his experience on IND filling for both US and China. Professor Shuangqing Peng had a topic on New Drug Safety Evaluation Approach. Dr. Baomin Xin, Medicilon VP of DMPK and BA,Read more
